These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 5095277)
1. Leucine equivalency system in managing branched chain ketoaciduria. Smith BA; Waisman HA J Am Diet Assoc; 1971 Oct; 59(4):342-6. PubMed ID: 5095277 [No Abstract] [Full Text] [Related]
2. [On the clinical picture and pathological anatomy of the maple syrup disease ("branded chain ketoaciduria"). Report on 2 cases in 1 family]. Sander C; Clotten R; Noetzel H; Wehinger H Dtsch Med Wochenschr; 1968 May; 93(18):895-903 passim. PubMed ID: 5650843 [No Abstract] [Full Text] [Related]
3. M aple syrup urine disease. A review with a report of an additional case. Schwartz JF; Kolendrianos ET Dev Med Child Neurol; 1969 Aug; 11(4):460-70. PubMed ID: 5805351 [No Abstract] [Full Text] [Related]
4. Plasma amino acid analyses in two cases of maple syrup urine disease. Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750 [TBL] [Abstract][Full Text] [Related]
5. [Dietetics in hereditary enzyme deficiencies]. Royer P Sem Hop; 1970 Feb; 46(10):653-9. PubMed ID: 4314674 [No Abstract] [Full Text] [Related]
6. Dietary treatment of maple sirup urine disease (branched-chain ketoaciduria). Noel MB; Stanley PB; Girz JC; Allen RJ J Am Diet Assoc; 1976 Jul; 69(1):62-8. PubMed ID: 932376 [No Abstract] [Full Text] [Related]
7. Biochemical studies on a variant of branched chain ketoaciduria in a 19-year-old female. Fischer MH; Gerritsen T Pediatrics; 1971 Nov; 48(5):795-801. PubMed ID: 5125877 [No Abstract] [Full Text] [Related]
9. DIETARY TREATMENT OF A CHILD WITH MAPLE SYRUP URINE DISEASE (BRANCHED-CHAIN KETOACIDURIA). WESTALL RG Arch Dis Child; 1963 Oct; 38(201):485-91. PubMed ID: 14065992 [No Abstract] [Full Text] [Related]
10. A new variant of maple syrup urine disease (branched chain ketoaciduria). Clinical and biochemical evaluation. Schulman JD; Lustberg TJ; Kennedy JL; Museles M; Seegmiller JE Am J Med; 1970 Jul; 49(1):118-24. PubMed ID: 5431474 [No Abstract] [Full Text] [Related]
11. Multiple exchange transfusions as treatment during the acute period in maple syrup urine disease. Schuchmann L; Witt I; Schulz P; Schumacher H; Rüdiger H Helv Paediatr Acta; 1972 Sep; 27(4):449-56. PubMed ID: 4644280 [No Abstract] [Full Text] [Related]
12. Clinical consequences of disorders in the intermediate metabolism of branched chain amino acids (valine, leucine and isoleucine). Mogoş T; Cheţa CP; Mincu IT Rom J Intern Med; 1994; 32(1):57-61. PubMed ID: 8081313 [TBL] [Abstract][Full Text] [Related]
13. [Compliance of the diet restricted with leucine, isoleucine and valine in maple syrup urine disease (MSUD) children]. Kowalik A; Narojek L; Sykut-Cegielska J Rocz Panstw Zakl Hig; 2007; 58(1):95-101. PubMed ID: 17711097 [TBL] [Abstract][Full Text] [Related]
14. [CLINICAL, BIOCHEMICAL, AND NEUROPATHOLOGIC ASPECTS OF MAPLE SYRUP URINE DISEASE. A KETOACIDURIA OF THE OPEN CHAIN AMINOACIDS LEUCINE, ISOLEUCINE AND VALINE]. SILBERMANSCHWARTZMAN J An Fac Med Lima; 1963 Sep; 46():339-65. PubMed ID: 14122039 [No Abstract] [Full Text] [Related]
15. The therapy of maple syrup urine disease. Snyderman SE Am J Dis Child; 1967 Jan; 113(1):68-73. PubMed ID: 6015908 [No Abstract] [Full Text] [Related]